Treatment of mice with multiple topical applications of 12-O-tetradecanoylphorbol-13-acetate (TPA) or diacylglycerol resulted in a preferential decrease in epidermal protein kinase C-β 2 (PKC-β 2 ) compared with PKC-α as determined by western analysis. When PKC-α was decreased by 40%, PKC-β 2 could no longer be detected, suggesting that PKC-β 2 is more sensitive to downregulation, and/or specific epidermal cell types that contain PKC-β 2 are more sensitive to TPA/diacylglycerol. To address this issue, we isolated Langerhans cells (LCs) from epidermal cell suspensions with immunomagnetic beads and an antibody to the class II major histocompatibility complex. Northern blot analysis revealed a PKC-β 2 signal in isolated LCs that was 40-fold greater than that observed in unfractionated epidermal cells, and no PKC-β 2 signal was detected in epidermal cells depleted of LCs, indicating that PKC-β 2 is expressed exclusively in LCs within the epidermis. Western blot analysis confirmed the presence of PKC-β 2 in LCs. PKC-β 2 was highly sensitive to downregulation, because a single application of TPA resulted in a 90% loss of PKC-β 2 within 6 h without a decrease in the number of LCs. To determine whether the decreased level of PKC-β 2 within LCs was associated with an alteration in contact hypersensitivity, we treated mice with only a single application of TPA, and 6 hours later mice were sensitized with 2,4-dinitrofluorobenzene on the same dorsal area. Subsequent challenge revealed a 60% decrease in contact hypersensitivity in TPA-treated mice. These data indicate that (i) within the epidermis, PKC-β 2 is highly sensitive to downregulation and is exclusively expressed in LCs, and (ii) the downregulation of PKC-β 2 is associated with impaired LC function with respect to contact hypersensitivity.